Akihiro Kitadate

1.1k total citations
57 papers, 710 citations indexed

About

Akihiro Kitadate is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Akihiro Kitadate has authored 57 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 20 papers in Molecular Biology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Akihiro Kitadate's work include Multiple Myeloma Research and Treatments (24 papers), Lymphoma Diagnosis and Treatment (15 papers) and Cutaneous lymphoproliferative disorders research (11 papers). Akihiro Kitadate is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), Lymphoma Diagnosis and Treatment (15 papers) and Cutaneous lymphoproliferative disorders research (11 papers). Akihiro Kitadate collaborates with scholars based in Japan and United States. Akihiro Kitadate's co-authors include Sho Ikeda, Hiroyuki Tagawa, Naoto Takahashi, Kosei Matsue, Masami Takeuchi, Kentaro Narita, Yoshiaki Abe, Hiroki Kobayashi, Daisuke Miura and Kazuaki Teshima and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Akihiro Kitadate

53 papers receiving 706 citations

Peers

Akihiro Kitadate
Alvaro J. Alencar United States
Qin Huang United States
Thérèse Rousset France
J.P. Vannier France
Rizwan Naeem United States
Ana‐Iris Schiefer Austria
Kirsten Herbert Australia
Audrey Sylvia Baur Switzerland
Emanuele S. G. d'Amore Italy
Tariq Muzzafar United States
Alvaro J. Alencar United States
Akihiro Kitadate
Citations per year, relative to Akihiro Kitadate Akihiro Kitadate (= 1×) peers Alvaro J. Alencar

Countries citing papers authored by Akihiro Kitadate

Since Specialization
Citations

This map shows the geographic impact of Akihiro Kitadate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Kitadate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Kitadate more than expected).

Fields of papers citing papers by Akihiro Kitadate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Kitadate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Kitadate. The network helps show where Akihiro Kitadate may publish in the future.

Co-authorship network of co-authors of Akihiro Kitadate

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Kitadate. A scholar is included among the top collaborators of Akihiro Kitadate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Kitadate. Akihiro Kitadate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Masahiro, et al.. (2024). Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect. International Journal of Hematology. 120(3). 325–336. 1 indexed citations
2.
Kitadate, Akihiro, et al.. (2024). Optimizing random skin biopsies: a review of techniques and indications for intravascular large B-cell lymphoma. International Journal of Hematology. 119(6). 619–625. 4 indexed citations
3.
Abe, Ko, Sho Ikeda, Miho Nara, et al.. (2023). Hypoxia‐induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase‐1 in multiple myeloma. Cancer Medicine. 12(8). 9709–9722. 9 indexed citations
4.
5.
Ikeda, Sho, et al.. (2022). Downregulation of miR‐26 promotes invasion and metastasis via targeting interleukin‐22 in cutaneous T‐cell lymphoma. Cancer Science. 113(4). 1208–1219. 12 indexed citations
6.
Kitadate, Akihiro. (2022). SY08-4 CD38-targeted therapy for multiple myeloma: Mechanisms of action and clinical development. Annals of Oncology. 33. S431–S431. 1 indexed citations
7.
Kitadate, Akihiro, et al.. (2022). High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma. International Journal of Hematology. 116(5). 712–722. 9 indexed citations
8.
Kobayashi, Takahiro, Akihiro Kitadate, Tomoko Yoshioka, et al.. (2022). Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 90(3). 279–284. 1 indexed citations
9.
Kitadate, Akihiro, et al.. (2020). Intravascular large B‐cell lymphoma diagnosed by incisional random skin biopsy after failure of diagnosis using punch biopsy: A case report. Journal of Cutaneous Pathology. 48(4). 589–591. 4 indexed citations
10.
Miura, Daisuke, Kentaro Narita, Rikako Tabata, et al.. (2019). Clinical and Prognostic Impact of (11;14)(q13;q32) Translocation on Patients with Multiple Myeloma. Blood. 134(Supplement_1). 5507–5507. 1 indexed citations
11.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2019). 18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. Clinical Nuclear Medicine. 45(2). e69–e71. 3 indexed citations
12.
Kobayashi, Hiroki, Toshiki Terao, Yoshiaki Abe, et al.. (2019). Evaluation of the safety and efficacy of daratumumab outside of clinical trials. International Journal of Hematology. 109(6). 665–672. 11 indexed citations
13.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2018). Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma. Annals of Hematology. 97(12). 2345–2352. 24 indexed citations
14.
Takeshima, Masahiro, Hiroyasu Ishikawa, Akihiro Kitadate, et al.. (2018). Anorexia nervosa-associated pancytopenia mimicking idiopathic aplastic anemia: a case report. BMC Psychiatry. 18(1). 150–150. 12 indexed citations
15.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2017). Normalization of the Serum Free Light Chain Ratio in Patients with Intact Immunoglobulin Multiple Myeloma Who Achieve Less Than Complete Response. Blood. 130. 5380–5380. 1 indexed citations
16.
17.
18.
Kitadate, Akihiro, Sho Ikeda, Naoto Takahashi, et al.. (2017). Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas. Haematologica. 103(1). 126–135. 19 indexed citations
19.
Ikeda, Sho, Akihiro Kitadate, Miho Nara, et al.. (2016). Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Oncotarget. 7(12). 13563–13574. 20 indexed citations
20.
Kitadate, Akihiro, Sho Ikeda, Kazuaki Teshima, et al.. (2015). MicroRNA-16 mediates the regulation of a senescence–apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Oncogene. 35(28). 3692–3704. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alvaro J. Alencar Breakdown of academic impact, for papers by Qin Huang Breakdown of academic impact, for papers by Thérèse Rousset Breakdown of academic impact, for papers by J.P. Vannier Breakdown of academic impact, for papers by Rizwan Naeem Breakdown of academic impact, for papers by Ana‐Iris Schiefer Breakdown of academic impact, for papers by Kirsten Herbert Breakdown of academic impact, for papers by Audrey Sylvia Baur Breakdown of academic impact, for papers by Emanuele S. G. d'Amore Breakdown of academic impact, for papers by Tariq Muzzafar
Rankless by CCL
2026